Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridaySep 11, 2020 10:55 am

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) CEO and LD Micro Founder Discuss Synergies in Conference Call

SRAX (NASDAQ: SRAX), a provider of digital-marketing and consumer data-management technology solutions, on Thursday held a conference call with its CEO Chris Miglino and LD Micro Founder Chris Lahiji. During the call, Miglino and Lahiji discussed SRAX’s acquisition of LD Micro and synergies of the combined companies. "Both physical and virtual events that LD Micro has done are seen as the gold standard within the industry and we look forward to taking that to the next level," Miglino said during the call. To view a recording of the conference call, visit http://nnw.fm/GJ8D9 About SRAX Inc. SRAX is a digital-marketing and…

Continue Reading

FridaySep 11, 2020 10:09 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at the H.C. Wainwright & Co. 22nd Annual Global Investment Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that CEO John Climaco will present virtually at the H.C. Wainwright & Co. 22nd Annual Global Investment Conference. According to the update, Climaco’s presentation is scheduled to begin at 9:30 a.m. EDT on Wednesday, September 16, 2020, and CNSP management will hold one-on-one virtual investor meetings at the event. Interested parties may register for the presentation by visiting http://ibn.fm/3BGwC . In addition, a replay of the presentation will be available on the company's…

Continue Reading

FridaySep 11, 2020 9:50 am

NetworkNewsBreaks – Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) Featured in Mizuho Securities Research Report

Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We are downgrading STSA shares to Neutral (from Buy) and lowering our price target (‘PT’) to $4 (from $32) following the disappointing top-line results from STS101, their intranasal dihydroergotamine (‘DHE’) in development for the acute treatment of migraine headaches. We spoke to management following the data release and, while they are still digesting the data and evaluating their options going forward, we see limited reasons for optimism and move to the sidelines on the stock.” To request access…

Continue Reading

ThursdaySep 10, 2020 1:18 pm

NetworkNewsBreaks – Macy’s, Inc. (NYSE: M) Featured in Analysis Report

Macy’s (NYSE: M) was featured in a recent analysis report highlighting the retailer ahead of its recently reported second quarter 2020 results (http://nnw.fm/ha4vb). The report, written by LikeFolio Founder Andy Swan, reads, “As ZM's report yesterday highlighted, changing quarantine behavior can create some big winners. But it can also highlight companies on the wrong side of the shift. cc: Macy's. After a brief digital bump in 20Q2, Purchase Intent in 20Q3 (1 month in) is pacing -7% YoY. Consumer happiness is dropping. From March to mid-June, sentiment fell 25 points. It is now setting in 12 points below March levels.”…

Continue Reading

ThursdaySep 10, 2020 1:07 pm

NetworkNewsBreaks – Rimini Street Inc. (NASDAQ: RMNI) Closes Public Offering of 6.1M Shares

Rimini Street (NASDAQ: RMNI), a global provider of enterprise software products and services, announced that it has closed an underwritten public offering of 6,100,000 primary shares of common stock. The company, which is also a leading third-party support provider for Oracle and SAP software products and a Salesforce partner, saw gross proceeds from the sale of approximately $27.5 million; the shares were sold at the public offering price of $4.50 per share. Rimini Street plans to use funds obtained from the public offering for working capital and other general corporate purposes. Roth Capital Partners acted as sole book-running manager for the…

Continue Reading

ThursdaySep 10, 2020 12:55 pm

NetworkNewsBreaks – Kingman Minerals Ltd. (TSX.V: KGS) Leverages Innovative Production Strategy as Gold Continues Its Reign

Kingman Minerals (TSX.V: KGS), a Canada-listed gold miner with extensive claims in key mining jurisdictions spanning North America, intends to increase gold production in anticipation of rising prices. Despite recent drops, the value of gold continues to endure and set record highs as investors shift capital to “safe haven” assets like precious metals. A recent article discussing this reads, “KGS anticipated the rising trend of gold prices long before they reached this critical point, sourcing historic mining sites throughout North America as part of its production strategy aimed at extracting the remaining gold left behind by previous generations through the…

Continue Reading

ThursdaySep 10, 2020 12:52 pm

NetworkNewsBreaks – Zoom Video Communications, Inc. (NASDAQ: ZM) Featured in Analysis Report

Zoom Video Communications (NASDAQ: ZM) was featured in a recent analysis report that detailed the company’s standing ahead of its recently released financial results for the quarter ended July 31, 2020. The report, written by LikeFolio Founder Andy Swan, reads, “Talk about being in the right place at the right time. Consumer demand and adoption of Zoom's video conferencing platform boomed during quarantine as consumers sought ways to stay connected socially and at work/school. Purchase Intent in 21Q2 was down 31% QoQ, but increased exponentially YoY. Download and usage mentions in 21Q3 reveals a seasonal uptick as students return to…

Continue Reading

ThursdaySep 10, 2020 12:28 pm

NetworkNewsBreaks – Manganese X Energy Corp. (TSX.V: MN) (FSE: 9SC2) (OTC: MNXXF) Produces High-Grade EV Battery Material with Development Partner

Manganese X Energy (TSXV: MN) (FSE: 9SC2) (OTC: MNXXF) announced that, working in conjunction with Kemetco Research Inc., the company has improved flowsheet optimization to produce high-grade battery material for the EV and stored-energy space. Manganese X Energy noted that it had received metallurgical results from Kemetco in the development process that demonstrate greater efficiency and improved economics leading to commercialization. The announcement noted that this “transformational achievement” demonstrates key resource material can be compliant with electric vehicles and other requirements. The two companies are working to produce ultra-high-purity, battery-grade manganese products for the growing electric-vehicle and energy storage sectors,…

Continue Reading

ThursdaySep 10, 2020 12:13 pm

NetworkNewsBreaks – The JBoy Show Features Heisman Trophy and National Championship Winner Charlie Ward

The JBoy Show, hosted by Jake Crain and providing an in-depth look at Southeastern Conference (“SEC”) sports, recently featured Heisman Trophy and National Championship game winner Charlie Ward. Crain introduces Ward as a dual-sport athlete who has played in the NBA and in football, a person with many accolades, having competed in pro basketball, as well as won a Heisman, a Davey O'Brien Award and a college football national championship. “Football and basketball are very similar,” Ward said when discussing his ability in both sports and mindset as a point guard and quarterback preparing to compete at a high level…

Continue Reading

ThursdaySep 10, 2020 12:09 pm

NetworkNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) Announces Promising Results From Second Preclinical Study of AV-101 – Probenecid Combination

VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, recently announced positive new data from the company's second preclinical study of its oral investigational drug, AV-101, in combination with probenecid. According to the update, results of the new study complement previous preclinical data demonstrating the combination's potential to substantially increase the brain concentration of AV-101's active metabolite, 7-Cl-KYN, a potent and selective full antagonist of the NMDA receptor glycine co-agonist site, thereby reducing NMDA receptor signaling. "These new positive results amplify our message that AV-101, when administered in…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000